Review



mouse methylation beadchip array (280 k)  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Illumina Inc mouse methylation beadchip array (280 k)
    Mouse Methylation Beadchip Array (280 K), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/mouse+methylation+beadchip/pmc11020883-3-26-25
    Average 90 stars, based on 1 article reviews
    mouse methylation beadchip array (280 k) - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Generated:

    Article Title: Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures
    Article Snippet: .. These datasets were generated using a combination of the Illumina mouse methylation array, whole genome bisulfite sequencing (WGBS), and reduced representation bisulfite sequencing (RRBS). ..

    Methylation:

    Article Title: Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures
    Article Snippet: .. These datasets were generated using a combination of the Illumina mouse methylation array, whole genome bisulfite sequencing (WGBS), and reduced representation bisulfite sequencing (RRBS). ..

    Article Title: Functionally enriched epigenetic clocks reveal tissue-specific discordant aging patterns in individuals with cancer
    Article Snippet: .. We defined mouse PCGTgen (mPCGTgen) and mouse PCGTnonage (mPCGTnonage) clocks as follows: (1) PCGT genes were identified using the same list as for human data (see “Identification of PCGT CpGs” above), converting human gene symbols into murine orthologs using the R package babelgene (version 22.9); (2) mouse PCGT CpGs were identified by filtering the annotation of the Illumina Methylation mouse array for murine PCGT gene symbol orthologs, keeping only genes located within 200 bp of a transcription start site (TSS200) and unmethylated in fetal mouse tissue (mean beta <0.2 across n = 41 fetal samples from the mouse methylation atlas (NCBI GEO GSE184410), including fetal brain ( n = 11), intestine ( n = 9), limb ( n = 10), and liver ( n = 11). ..

    Article Title: Selective epigenetic alterations in RNF43 in pancreatic exocrine cells from high-fat-diet-induced obese mice; implications for pancreatic cancer
    Article Snippet: .. We analyzed the methylation levels of 197 loci in six genes ( KRAS , CDKN2A , TP53 , SMAD4 , GNAS and RNF43 ) using Illumina Mouse Methylation BeadChip array (280 K) data from pancreatic exocrine cells obtained from high-fat-diet (HFD) induced obese mice. ..

    Article Title: Setd1a Loss-of-function Disrupts Epigenetic Regulation of Ribosomal Genes via Altered DNA Methylation.
    Article Snippet: .. Study Design: We profiled DNA methylation in the frontal cortex of Setd1a+/− mice across prenatal and postnatal development using Illumina Mouse Methylation arrays. ..

    Article Title: Abstracts From the 55th Annual Meeting of the Environmental Mutagenesis and Genomics Society, September 7 – 11, 2024 ‐ Palm Springs, CA, USA, An Oasis of DNA Discoveries
    Article Snippet: The base-paired double-helical DNA structure provides the mechanism for its replication, but the information redundancy in the complementary strands is also essential to preserve the genetic instructions when one of the strands is damaged or mutated.. The discoveries of excision-repair, double-strand break repair and recombinational mechanisms validate the role of the duplex structure for preservation of the genome.. They also contribute to the development of gene editing tools to facilitate alterations at precise points in the genome, thereby replacing the tedious process of generating mutants and selecting ones that are needed for mechanistic studies.

    Methylation Sequencing:

    Article Title: Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures
    Article Snippet: .. These datasets were generated using a combination of the Illumina mouse methylation array, whole genome bisulfite sequencing (WGBS), and reduced representation bisulfite sequencing (RRBS). ..

    Article Title: Abstracts From the 55th Annual Meeting of the Environmental Mutagenesis and Genomics Society, September 7 – 11, 2024 ‐ Palm Springs, CA, USA, An Oasis of DNA Discoveries
    Article Snippet: The base-paired double-helical DNA structure provides the mechanism for its replication, but the information redundancy in the complementary strands is also essential to preserve the genetic instructions when one of the strands is damaged or mutated.. The discoveries of excision-repair, double-strand break repair and recombinational mechanisms validate the role of the duplex structure for preservation of the genome.. They also contribute to the development of gene editing tools to facilitate alterations at precise points in the genome, thereby replacing the tedious process of generating mutants and selecting ones that are needed for mechanistic studies.

    DNA Methylation Assay:

    Article Title: Setd1a Loss-of-function Disrupts Epigenetic Regulation of Ribosomal Genes via Altered DNA Methylation.
    Article Snippet: .. Study Design: We profiled DNA methylation in the frontal cortex of Setd1a+/− mice across prenatal and postnatal development using Illumina Mouse Methylation arrays. ..

    Article Title: Abstracts From the 55th Annual Meeting of the Environmental Mutagenesis and Genomics Society, September 7 – 11, 2024 ‐ Palm Springs, CA, USA, An Oasis of DNA Discoveries
    Article Snippet: The base-paired double-helical DNA structure provides the mechanism for its replication, but the information redundancy in the complementary strands is also essential to preserve the genetic instructions when one of the strands is damaged or mutated.. The discoveries of excision-repair, double-strand break repair and recombinational mechanisms validate the role of the duplex structure for preservation of the genome.. They also contribute to the development of gene editing tools to facilitate alterations at precise points in the genome, thereby replacing the tedious process of generating mutants and selecting ones that are needed for mechanistic studies.

    other:

    Article Title: Senolytic-facilitated Reversal of End-Organ Dysfunction in a Murine Model of Obstructive Sleep Apnea
    Article Snippet: Published December 19, 2023 as 10.1164/rccm.202306-1101OC Copyright © 2023 by the American Thoracic Society Mouse Methylation BeadChip (Illumina, San Diego, CA).

    Article Title: TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states.
    Article Snippet: The bisulfite-converted DNA was processed using the Illumina mouse methylation array protocol.



    Similar Products

    90
    INFINIUM Inc mouse methylation-12v1-0 beadchip array
    Mouse Methylation 12v1 0 Beadchip Array, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/infinium+humanmethylation450+beadchip/pmc12016927-66-29-28
    Average 90 stars, based on 1 article reviews
    mouse methylation-12v1-0 beadchip array - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    INFINIUM Inc mouse methylation beadchip arrays
    Mouse Methylation Beadchip Arrays, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/infinium+humanmethylation450+beadchip/pmc11735619-45-32-31
    Average 90 stars, based on 1 article reviews
    mouse methylation beadchip arrays - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    INFINIUM Inc mouse methylation beadchip array
    Mouse Methylation Beadchip Array, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/infinium+humanmethylation450+beadchip/pmc11500418-343-17-16
    Average 90 stars, based on 1 article reviews
    mouse methylation beadchip array - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    95
    Zymo Research mouse dna methylation beadchip array
    Mouse Dna Methylation Beadchip Array, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/Universal+Methylated+Mouse+DNA+Standard/pm39237615-582-0-11
    Average 95 stars, based on 1 article reviews
    mouse dna methylation beadchip array - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    90
    Illumina Inc beadchip mouse methylation array
    Beadchip Mouse Methylation Array, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/mouse+methylation+beadchip/10__1002_slash_em__22620-70-0-1
    Average 90 stars, based on 1 article reviews
    beadchip mouse methylation array - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    INFINIUM Inc custom beadchip array containing loci from the infinium mouse methylation beadchip
    a , Scatter plots showing DNA <t>methylation</t> level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array <t>(mm285k)</t> across different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially methylated locus (DML), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). For each plot, the line represents linear fit. The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Inset of left upper panel: symbol for DNA methylation. b , Summary bar plot of the proportions of DML among the mm285k array sites under different categories (as specified in the inset of a ). c , Similar to b , but for DML among the imputed mammalian conserved sites covered by the mammalian 40k array (mm40k). Sample sizes for the various tissue organs (young adult vehicle, aged vehicle, aged exenatide): hypothalamus (4, 4, 5), frontal cortex (8, 8, 8), hippocampus (8, 8, 8), adipose tissue (8, 8, 8), liver (8, 8, 8), circulating WBCs (5, 9, 6), heart (8, 8, 8), kidney (7, 9, 8), skeletal muscle (8, 8, 8), colon (7, 9, 8), spleen (8, 8, 8).
    Custom Beadchip Array Containing Loci From The Infinium Mouse Methylation Beadchip, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/custom+beadchip+array+containing+loci+from+the+infinium+mouse+methylation+beadchip/bio_rxiv__2024__05__06__592653-280-20-19
    Average 90 stars, based on 1 article reviews
    custom beadchip array containing loci from the infinium mouse methylation beadchip - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc mouse methylation beadchip array (280 k)
    a , Scatter plots showing DNA <t>methylation</t> level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array <t>(mm285k)</t> across different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially methylated locus (DML), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). For each plot, the line represents linear fit. The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Inset of left upper panel: symbol for DNA methylation. b , Summary bar plot of the proportions of DML among the mm285k array sites under different categories (as specified in the inset of a ). c , Similar to b , but for DML among the imputed mammalian conserved sites covered by the mammalian 40k array (mm40k). Sample sizes for the various tissue organs (young adult vehicle, aged vehicle, aged exenatide): hypothalamus (4, 4, 5), frontal cortex (8, 8, 8), hippocampus (8, 8, 8), adipose tissue (8, 8, 8), liver (8, 8, 8), circulating WBCs (5, 9, 6), heart (8, 8, 8), kidney (7, 9, 8), skeletal muscle (8, 8, 8), colon (7, 9, 8), spleen (8, 8, 8).
    Mouse Methylation Beadchip Array (280 K), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+methylation+beadchip+array/mouse+methylation+beadchip/pmc11020883-3-26-25
    Average 90 stars, based on 1 article reviews
    mouse methylation beadchip array (280 k) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    a , Scatter plots showing DNA methylation level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially methylated locus (DML), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). For each plot, the line represents linear fit. The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Inset of left upper panel: symbol for DNA methylation. b , Summary bar plot of the proportions of DML among the mm285k array sites under different categories (as specified in the inset of a ). c , Similar to b , but for DML among the imputed mammalian conserved sites covered by the mammalian 40k array (mm40k). Sample sizes for the various tissue organs (young adult vehicle, aged vehicle, aged exenatide): hypothalamus (4, 4, 5), frontal cortex (8, 8, 8), hippocampus (8, 8, 8), adipose tissue (8, 8, 8), liver (8, 8, 8), circulating WBCs (5, 9, 6), heart (8, 8, 8), kidney (7, 9, 8), skeletal muscle (8, 8, 8), colon (7, 9, 8), spleen (8, 8, 8).

    Journal: bioRxiv

    Article Title: Functional and multi-omic aging rejuvenation with GLP-1R agonism

    doi: 10.1101/2024.05.06.592653

    Figure Lengend Snippet: a , Scatter plots showing DNA methylation level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially methylated locus (DML), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). For each plot, the line represents linear fit. The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Inset of left upper panel: symbol for DNA methylation. b , Summary bar plot of the proportions of DML among the mm285k array sites under different categories (as specified in the inset of a ). c , Similar to b , but for DML among the imputed mammalian conserved sites covered by the mammalian 40k array (mm40k). Sample sizes for the various tissue organs (young adult vehicle, aged vehicle, aged exenatide): hypothalamus (4, 4, 5), frontal cortex (8, 8, 8), hippocampus (8, 8, 8), adipose tissue (8, 8, 8), liver (8, 8, 8), circulating WBCs (5, 9, 6), heart (8, 8, 8), kidney (7, 9, 8), skeletal muscle (8, 8, 8), colon (7, 9, 8), spleen (8, 8, 8).

    Article Snippet: DNA methylation assays were carried out by the Clock Foundation using a custom BeadChip array containing loci from the Infinium Mouse Methylation BeadChip (i.e., mm285k array ) and the mammalian methylation array (i.e., mm40k array ).

    Techniques: DNA Methylation Assay, Methylation, Comparison

    a , Schematic of experimental design for the aged short-term treatment cohort. The animals either received hypothalamic injection of adeno-associated virus vector (AAV) for the expression of shRNA to knockdown Glp1r or scramble shRNA, and either received vehicle, exenatide, or rapamycin treatment. Abbreviations: HTH, hypothalamus. KD, knockdown. OGTT: oral glucose tolerance test. b , Mean (±S.D.) hypothalamic Glp1r transcript expression levels measured with quantitative PCR ( n = 3 mice from each group used for the comparison), relative to the mean of aged control group (i.e., hypothalamic scramble shRNA-AAV injection, treated with vehicle). c , Scatter plots showing transcriptomic changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially expressed gene (DEG), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). Inset of left panel: symbol for transcript. d , Summary bar plot of the proportions of DEGs under different categories (as specified in the inset of c ). e and f , Similar to c and d , but for showing exenatide treatment effects in aged animals with hypothalamic Glp1r knockdown. g , Scatter plots showing DNA methylation level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating WBCs. Each dot represents one differentially methylated locus (DML), color-coded by treatment (Rx) effect categories (as shown in the inset of c ). Inset of left panel: symbol for DNA methylation. h , Similar to g , but for showing exenatide treatment effects in aged animals with hypothalamic Glp1r knockdown. i , Scatter plot showing plasma metabolomic changes in aging ( x -axis) vs. exenatide treatment ( y -axis). Each dot represents one metabolite. j , Similar to i , but for showing exenatide treatment effects in aged animals with hypothalamic Glp1r knockdown. In c , e , and g – j , the lines represent linear fits (with confidence interval (grey) in i and j ). The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Sample sizes for data in c – j : n = 5 mice for each experimental group for the various tissues, except n = 4 aged exenatide-treated mice (src group) for circulating WBCs transcriptomic profiling.

    Journal: bioRxiv

    Article Title: Functional and multi-omic aging rejuvenation with GLP-1R agonism

    doi: 10.1101/2024.05.06.592653

    Figure Lengend Snippet: a , Schematic of experimental design for the aged short-term treatment cohort. The animals either received hypothalamic injection of adeno-associated virus vector (AAV) for the expression of shRNA to knockdown Glp1r or scramble shRNA, and either received vehicle, exenatide, or rapamycin treatment. Abbreviations: HTH, hypothalamus. KD, knockdown. OGTT: oral glucose tolerance test. b , Mean (±S.D.) hypothalamic Glp1r transcript expression levels measured with quantitative PCR ( n = 3 mice from each group used for the comparison), relative to the mean of aged control group (i.e., hypothalamic scramble shRNA-AAV injection, treated with vehicle). c , Scatter plots showing transcriptomic changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially expressed gene (DEG), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). Inset of left panel: symbol for transcript. d , Summary bar plot of the proportions of DEGs under different categories (as specified in the inset of c ). e and f , Similar to c and d , but for showing exenatide treatment effects in aged animals with hypothalamic Glp1r knockdown. g , Scatter plots showing DNA methylation level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating WBCs. Each dot represents one differentially methylated locus (DML), color-coded by treatment (Rx) effect categories (as shown in the inset of c ). Inset of left panel: symbol for DNA methylation. h , Similar to g , but for showing exenatide treatment effects in aged animals with hypothalamic Glp1r knockdown. i , Scatter plot showing plasma metabolomic changes in aging ( x -axis) vs. exenatide treatment ( y -axis). Each dot represents one metabolite. j , Similar to i , but for showing exenatide treatment effects in aged animals with hypothalamic Glp1r knockdown. In c , e , and g – j , the lines represent linear fits (with confidence interval (grey) in i and j ). The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Sample sizes for data in c – j : n = 5 mice for each experimental group for the various tissues, except n = 4 aged exenatide-treated mice (src group) for circulating WBCs transcriptomic profiling.

    Article Snippet: DNA methylation assays were carried out by the Clock Foundation using a custom BeadChip array containing loci from the Infinium Mouse Methylation BeadChip (i.e., mm285k array ) and the mammalian methylation array (i.e., mm40k array ).

    Techniques: Injection, Virus, Plasmid Preparation, Expressing, shRNA, Real-time Polymerase Chain Reaction, Comparison, DNA Methylation Assay, Methylation

    a , Longitudinal changes in average daily food intake per mouse for animals in the different experimental groups (monitored weekly). Abbreviations: scr, scramble shRNA group; KD, knockdown group. b , Mean (±S.D.) body weight of the animal groups throughout the treatment period (monitored weekly). c , Oral glucose tolerance test (OGTT) results for the different experimental groups at the end of 13-week treatment (Rx) period. P -value: one-way ANOVA with Holm-Sidak’s post-hoc multiple comparisons test for area under the curve (AUC). d , Gonadal fat weight as percentage of body weight in the different experimental groups. P -value: one-way ANOVA with Tukey’s post-hoc test for multiple comparisons. e , Scatter plots showing transcriptomic changes with exenatide treatment in aged control (scramble shRNA) mice ( x -axis) vs. hypothalamic (HTH) Glp1r knockdown ( y -axis) mice across the different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially expressed gene (DEG), color-coded by treatment (Rx) effect categories as shown in the inset (same or opposite Rx effects; dominant in scr or KD: statistically significant in the respective comparison only; no additional label: significant for both comparisons, also see Methods ). Inset of left panel: symbol for transcript. f , Similar to e , but showing the results for exenatide treatment-induced differentially methylated loci (DML) covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating WBCs. Inset of left panel: symbol for DNA methylation. g , Scatter plot showing plasma metabolomic changes with exenatide treatment in aged control (scramble shRNA) mice ( x -axis) vs. HTH Glp1r knockdown ( y -axis) mice. For each plot in e – g , the line represents linear fit (with confidence interval (grey) in g ). The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Sample sizes for data in all plots: n = 5 mice for each experimental group for the various tissues, except n = 4 aged exenatide-treated mice for circulating WBCs transcriptomic profiling.

    Journal: bioRxiv

    Article Title: Functional and multi-omic aging rejuvenation with GLP-1R agonism

    doi: 10.1101/2024.05.06.592653

    Figure Lengend Snippet: a , Longitudinal changes in average daily food intake per mouse for animals in the different experimental groups (monitored weekly). Abbreviations: scr, scramble shRNA group; KD, knockdown group. b , Mean (±S.D.) body weight of the animal groups throughout the treatment period (monitored weekly). c , Oral glucose tolerance test (OGTT) results for the different experimental groups at the end of 13-week treatment (Rx) period. P -value: one-way ANOVA with Holm-Sidak’s post-hoc multiple comparisons test for area under the curve (AUC). d , Gonadal fat weight as percentage of body weight in the different experimental groups. P -value: one-way ANOVA with Tukey’s post-hoc test for multiple comparisons. e , Scatter plots showing transcriptomic changes with exenatide treatment in aged control (scramble shRNA) mice ( x -axis) vs. hypothalamic (HTH) Glp1r knockdown ( y -axis) mice across the different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially expressed gene (DEG), color-coded by treatment (Rx) effect categories as shown in the inset (same or opposite Rx effects; dominant in scr or KD: statistically significant in the respective comparison only; no additional label: significant for both comparisons, also see Methods ). Inset of left panel: symbol for transcript. f , Similar to e , but showing the results for exenatide treatment-induced differentially methylated loci (DML) covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating WBCs. Inset of left panel: symbol for DNA methylation. g , Scatter plot showing plasma metabolomic changes with exenatide treatment in aged control (scramble shRNA) mice ( x -axis) vs. HTH Glp1r knockdown ( y -axis) mice. For each plot in e – g , the line represents linear fit (with confidence interval (grey) in g ). The Spearman correlation coefficients ( R S ) and associated P -values are also shown. Sample sizes for data in all plots: n = 5 mice for each experimental group for the various tissues, except n = 4 aged exenatide-treated mice for circulating WBCs transcriptomic profiling.

    Article Snippet: DNA methylation assays were carried out by the Clock Foundation using a custom BeadChip array containing loci from the Infinium Mouse Methylation BeadChip (i.e., mm285k array ) and the mammalian methylation array (i.e., mm40k array ).

    Techniques: shRNA, Comparison, Methylation, DNA Methylation Assay

    a , Scatter plots showing transcriptomic changes in aging ( x -axis) vs. rapamycin treatment ( y -axis) in different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially expressed gene (DEG), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). Inset of left panel: symbol for transcript. b , Summary bar plot of the proportions of differentially expressed genes (DEGs) under different categories (as specified in the inset of a ). c , Scatter plots showing DNA methylation level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating WBCs. Each dot represents one differentially methylated locus (DML), color-coded by treatment Rx effect categories (as shown in the inset of a ). Inset of left panel: symbol for DNA methylation. d , Scatter plot showing plasma metabolomic changes in aging ( x -axis) vs. rapamycin treatment ( y -axis). Each dot represents one metabolite. e , f , and g , Scatter plots showing transcriptomic ( e ), DNA methylation level ( f ), and plasma metabolomic ( g ) changes with rapamycin ( x -axis) vs. exenatide ( y -axis) treatment. Inset of e , DEG and DML categories, indicating: same or opposite Rx effects; GLP-1RA- or mTORi-dominant: statistically significant in the respective comparison only; no additional label: significant for both Rx effect comparisons (also see Methods ). Inset of left panels of e and f : symbols for transcript and DNA methylation, respectively. In a , c – g , the lines represent linear fits (with confidence interval (grey) in d and g ). The Spearman correlation coefficients ( R S ) and associated P -values are also shown. h , Heatmap showing the normalized expression (Norm. exp.) levels of significant differentially expressed gene modules with exenatide and/or rapamycin treatment. Inset (left) shows the color coding for tissue origin and Rx effect category (i.e., significant with exenatide, rapamycin, or both treatments). i , Bubble chart showing the gene ontology–biological process (GO:BP) pathways with significant enrichment among the different treatment-upregulated gene modules with exenatide and/or rapamycin treatment (top 3 for each tissue organ/circulating WBCs plotted). Gene count is represented with bubble size. Tissue origin and Rx effect category are color-coded as per the inset. j , Similar to i , but for treatment-downregulated gene modules. Sample sizes for all plots: n = 5 mice for each experimental group for the various tissues, except n = 4 aged exenatide- and 4 rapamycin-treated mice for circulating WBCs transcriptomic profiling.

    Journal: bioRxiv

    Article Title: Functional and multi-omic aging rejuvenation with GLP-1R agonism

    doi: 10.1101/2024.05.06.592653

    Figure Lengend Snippet: a , Scatter plots showing transcriptomic changes in aging ( x -axis) vs. rapamycin treatment ( y -axis) in different tissue organs and circulating white blood cells (WBCs). Each dot represents one differentially expressed gene (DEG), color-coded by treatment (Rx) effect categories as shown in the inset (rejuvenation: opposing aging and Rx effects; exacerbation: same aging and Rx effects; aging- or Rx-dominant: statistically significant in the respective comparison only; no additional label: significant for both aging and Rx effect comparisons, also see Methods ). Inset of left panel: symbol for transcript. b , Summary bar plot of the proportions of differentially expressed genes (DEGs) under different categories (as specified in the inset of a ). c , Scatter plots showing DNA methylation level changes in aging ( x -axis) vs. exenatide treatment ( y -axis) in sites covered by the Illumina mouse 285k array (mm285k) across different tissue organs and circulating WBCs. Each dot represents one differentially methylated locus (DML), color-coded by treatment Rx effect categories (as shown in the inset of a ). Inset of left panel: symbol for DNA methylation. d , Scatter plot showing plasma metabolomic changes in aging ( x -axis) vs. rapamycin treatment ( y -axis). Each dot represents one metabolite. e , f , and g , Scatter plots showing transcriptomic ( e ), DNA methylation level ( f ), and plasma metabolomic ( g ) changes with rapamycin ( x -axis) vs. exenatide ( y -axis) treatment. Inset of e , DEG and DML categories, indicating: same or opposite Rx effects; GLP-1RA- or mTORi-dominant: statistically significant in the respective comparison only; no additional label: significant for both Rx effect comparisons (also see Methods ). Inset of left panels of e and f : symbols for transcript and DNA methylation, respectively. In a , c – g , the lines represent linear fits (with confidence interval (grey) in d and g ). The Spearman correlation coefficients ( R S ) and associated P -values are also shown. h , Heatmap showing the normalized expression (Norm. exp.) levels of significant differentially expressed gene modules with exenatide and/or rapamycin treatment. Inset (left) shows the color coding for tissue origin and Rx effect category (i.e., significant with exenatide, rapamycin, or both treatments). i , Bubble chart showing the gene ontology–biological process (GO:BP) pathways with significant enrichment among the different treatment-upregulated gene modules with exenatide and/or rapamycin treatment (top 3 for each tissue organ/circulating WBCs plotted). Gene count is represented with bubble size. Tissue origin and Rx effect category are color-coded as per the inset. j , Similar to i , but for treatment-downregulated gene modules. Sample sizes for all plots: n = 5 mice for each experimental group for the various tissues, except n = 4 aged exenatide- and 4 rapamycin-treated mice for circulating WBCs transcriptomic profiling.

    Article Snippet: DNA methylation assays were carried out by the Clock Foundation using a custom BeadChip array containing loci from the Infinium Mouse Methylation BeadChip (i.e., mm285k array ) and the mammalian methylation array (i.e., mm40k array ).

    Techniques: Comparison, DNA Methylation Assay, Methylation, Expressing